Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to…

By C. Furberg, J. Wright, Barry R. Davis, J. Cutler, M. Alderman, H. Black, W. Cushman, R. Grimm, L. Haywood, F. Leenen and 47 more. Journal of the American Medical Association (JAMA), 2002

5,360 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine

View Paper: https://www.semanticscholar.org/paper/66cc4f92a3d2a9e339d2b1d8966ea6a61fbb6e9e

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. R. Redberg
2. F. Cosentino
3. Joshua A. Beckman
4. F. Paneni
5. S. Grundy
6. M. Creager

Citations in the corpus

• Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II. (2013, background): “the primary outcome of fatal coronary heart disease or non-fatal myocardial infarction among the chlorthalidone, amlodipine, and lisinopril arms in patients with diabetes.(92) Thus, if the primary goal of treatment is the reduction of blood pressure, then a thiazide diuretic, dihydropyridine calcium”